CLINICAL_TRIALS
trial_result
· 2024-02-05
Clinical Trial Update: Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD Patients [Phase 3]
Summary
Phase 3 trial evaluating pharmacogenetic information using NEUROPHARMAGEN in the treatment of major depressive disorder has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AB Biotics, SA | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED